Alto Neuroscience (ANRO) Retained Earnings (2023 - 2026)
Alto Neuroscience (ANRO) reported Retained Earnings of $13000.0 for Q1 2026, down 7.14% on a YoY basis from $14000.0 in Q1 2025, and down 100.0% sequentially from $352.8 million in Q4 2025.
Alto Neuroscience (ANRO) Retained Earnings (2023 - 2026) Analysis & Trends
Alto Neuroscience (ANRO) has 4 years of Retained Earnings data on file, last reported at $13000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 7.14% year-over-year to $13000.0; the trailing twelve-month figure through Mar 2026 stood at $13000.0 (down 7.14% YoY), and the FY2025 full-year result was $352.8 million, up 354.89% from the prior year.
- Retained Earnings declined to $13000.0 in Q1 2026, from $352.8 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $352.8 million in Q4 2025 to a low of -$185.5 million in Q3 2025.
- A 4-year average of -$7.0 million and a median of -$45.2 million in 2023 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings sank 175084.81% in 2024 and soared 354.89% in 2025, its largest moves.
- Tracing ANRO's Retained Earnings over 4 years: stood at -$79000.0 in 2023, then slumped by 175084.81% to -$138.4 million in 2024, then soared by 354.89% to $352.8 million in 2025, then tumbled by 100.0% to $13000.0 in 2026.
- Business Quant data shows ANRO's Retained Earnings at $13000.0 in Q1 2026, $352.8 million in Q4 2025, and -$185.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Alto Neuroscience | 881.86 Mn | 881.86 Mn | - | 13,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,000.00 |
| Dec 31, 2025 | 352.75 Mn |
| Sep 30, 2025 | -185.50 Mn |
| Jun 30, 2025 | -171.30 Mn |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | -138.40 Mn |
| Sep 30, 2024 | -123.20 Mn |
| Jun 30, 2024 | 286.27 Mn |
| Mar 31, 2024 | -90.38 Mn |
| Dec 31, 2023 | -79,000.00 |